Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Avid Radiopharmaceuticals"
Count: 67
Selected: 0
NCT0577560118F-LY3950321-01 Biodistribution and Safety Study
NCT01565382Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)
NCT04721756Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
NCT04474405Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
NCT04468347Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
NCT03052972Flortaucipir 18F PET Imaging in BIOCARD Study
NCT03040713Flortaucipir PET Imaging in Subjects With FTD
NCT02016560Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
NCT02278367Clinical Evaluation of Flortaucipir F 18
NCT02278354Tau Imaging in Professional Fighters
NCT03901092A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
NCT0251604618F-AV-1451 Autopsy Study
NCT0207976618F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
NCT02051764Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
NCT01992380A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
NCT03901105Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
NCT02167594Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
NCT03467477Tau Screening Study in Subjects With Early Symptomatic AD
NCT03322462Tau Screening Study in Patients With Early Symptomatic AD
NCT02795780Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
NCT02336360Augmenting Flortaucipir Dosimetry Estimates
NCT01515384A Trial of 18F-AV-133 Positron Emission Tomography (PET)
NCT02918539Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
NCT0235063418F-AV-1451 High Resolution Autopsy Study
NCT01518374Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
NCT02120664Florbetapir Calibration to the Centiloid Scale
NCT01550484A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
NCT01703702Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
NCT0251202918F-AV-1451 PET Imaging in TBI
NCT01710371Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
NCT02051790Evaluation of Reader Training Processes
NCT02107599The Feasibility of Florbetapir Quantitation in Europe
NCT01946243The Feasibility of Florbetapir Quantitation
NCT02029547Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
NCT01890343Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
NCT01662882A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
NCT01660815A Study of Florbetapir (18F) in Japanese Healthy Volunteers
NCT01733355A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
NCT01723488A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
NCT01400425Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
NCT00857506Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
NCT00857532Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
NCT01503944A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
NCT00855868Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
NCT01565330A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
NCT01565369Evaluation of Physician Training Methods to Read Florbetapir-PET Scans
NCT01565356Evaluation of PET Scan Timing Relative to AV-45 Injection Time
NCT01550549Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
NCT01447719Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
NCT00857415Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain